BMP-2 vs EGF
Head-to-head comparison of BMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and EGF (Human Epidermal Growth Factor) — benefits, dosing, side effects, research data, and where to buy.
| Property | BMP-2 | EGF |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Recombinant Human Bone Morphogenetic Protein-2 | Human Epidermal Growth Factor |
| Molecular Weight | 26000 Da | 6.0 kDa |
| Half-Life | short, localized exposure | minutes |
| Amino Acids | 114 | 53 |
| Typical Dose | 1.5 mg/mL local implant | 0.04–0.1 mg/cm²/day |
| Route | Local/Implant | Topical |
| Purity | ≥98% | ≥98% |
| Studies Count | 1500 | 650 |
| Research Status | Clinical | Clinical |
BMP-2 Benefits
- ✓promotes osteogenesis
- ✓supports nonunion healing
- ✓enhances scaffold-based repair
- ✓may improve defect fill
EGF Benefits
- ✓re-epithelialization
- ✓fibroblast activation
- ✓angiogenesis support
- ✓faster ulcer closure
BMP-2 Dosing
local implantation on collagen sponge|single intraoperative dose|procedure-specific scaffold delivery
EGF Dosing
Topical daily|0.04–0.1 mg/cm²|short courses until granulation/closure
BMP-2 Side Effects
- ⚠local inflammation
- ⚠ectopic bone formation
- ⚠edema
EGF Side Effects
- ⚠local irritation
- ⚠erythema
- ⚠theoretical hyperproliferation
- ⚠pain at site
Research Overview
BMP-2
rhBMP-2 has strong clinical and translational literature for bone regeneration, spinal fusion, and defect repair. Its use is primarily local because systemic exposure is not the intended mechanism.
EGF
Human and animal studies show EGF can accelerate epithelial migration and wound closure, especially in burns, ulcers, and mucosal injury. Its best evidence is for topical or local delivery because systemic exposure is brief and the effect is highly localized.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.